Loading...
AGC Inc.
ASGLY•PNK
Basic Materials
Chemicals - Specialty
$5.76
$-0.40(-6.49%)
AGC Inc. (ASGLY) Financial Performance & Income Statement Overview
Review AGC Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.39%
↑ 2.39%
Operating Income Growth
-2.29%
↓ 2.29%
Net Income Growth
-242.93%
↓ 242.93%
Operating Cash Flow Growth
34.002%
↑ 34.002%
Operating Margin
5.72%
↑ 5.72%
Gross Margin
23.62%
↑ 23.62%
Net Profit Margin
-6.85%
↓ 6.85%
ROE
-7.18%
↓ 7.18%
ROIC
3.92%
↑ 3.92%
AGC Inc. (ASGLY) Income Statement & Financial Overview
Review AGC Inc.'s (ASGLY) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $499.58B | $533.38B | $519.03B | $516.46B |
| Cost of Revenue | $383.03B | $406.10B | $387.49B | $391.39B |
| Gross Profit | $116.56B | $127.28B | $131.54B | $125.06B |
| Gross Profit Ratio | $0.23 | $0.24 | $0.25 | $0.24 |
| R&D Expenses | $0.00 | $61.37B | $157.00M | $14.90B |
| SG&A Expenses | $91.49B | $34.99B | $94.86B | $78.16B |
| Operating Expenses | $91.49B | $95.46B | $94.22B | $93.06B |
| Total Costs & Expenses | $474.52B | $501.56B | $482.36B | $484.45B |
| Interest Income | $2.83B | $2.34B | $2.72B | $2.92B |
| Interest Expense | $4.11B | $3.95B | $4.61B | $4.29B |
| Depreciation & Amortization | $44.26B | $44.49B | $45.26B | $45.98B |
| EBITDA | $64.56B | $75.40B | $67.21B | -$36.36B |
| EBITDA Ratio | $0.13 | $0.14 | $0.13 | -$0.07 |
| Operating Income | $25.07B | $31.82B | $36.67B | $32.00B |
| Operating Income Ratio | $0.05 | $0.06 | $0.07 | $0.06 |
| Other Income/Expenses (Net) | -$8.88B | -$7.48B | -$19.33B | -$118.63B |
| Income Before Tax | $16.18B | $24.34B | $17.35B | -$86.63B |
| Income Before Tax Ratio | $0.03 | $0.05 | $0.03 | -$0.17 |
| Income Tax Expense | $8.47B | $7.85B | $5.66B | $3.55B |
| Net Income | $6.65B | $12.37B | $8.09B | -$93.54B |
| Net Income Ratio | $0.01 | $0.02 | $0.02 | -$0.18 |
| EPS | $31.35 | $58.35 | $38.11 | -$441.20 |
| Diluted EPS | $31.29 | $58.35 | $38.11 | -$441.20 |
| Weighted Avg Shares Outstanding | $211.98M | $211.96M | $212.28M | $212.02M |
| Weighted Avg Shares Outstanding (Diluted) | $212.37M | $211.96M | $212.28M | $212.02M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan